Nanobiotix
NBTX
6 hedge funds and large institutions have $13.3M invested in Nanobiotix in 2022 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 2 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 6 → 6 (0)
0.03% less ownership
Funds ownership: 9.99% → 9.97% (-0.03%)
49% less capital invested
Capital invested by funds: $26M → $13.3M (-$12.7M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
Woodline Partners
San Francisco,
California
|
-$23K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$4.18K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Baillie Gifford & Co
Edinburgh,
United Kingdom
| $5.39M | – | – | – |
|
|
PA
2
Perceptive Advisors
New York
| $4.03M | – | – | – |
|
|
AG
3
Artal Group
Luxembourg
| $3.8M | – | – | – |
|
|
WP
4
Woodline Partners
San Francisco,
California
| $49K | -$23K | -4,279 | -25% |
|
|
5
UBS Group
Zurich,
Switzerland
| $11K | -$4.18K | -778 | -20% |
|
|
AWM
6
Activest Wealth Management
Aventure,
Florida
| $1K | – | – | – |
|
NBTX Hedge Fund Activity: Q2 2022 in Review
6 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Nanobiotix (NBTX) for Q2 2022, worth a combined $13.3M — down 49% from $26M a quarter earlier.
Fund positioning in NBTX was balanced in Q2 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.
The largest seller was Woodline Partners, cutting an estimated $23K.
- 6 institutional investors held Nanobiotix (NBTX) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $13.3M of Nanobiotix stock for Q2 2022, down 49% quarter-over-quarter.
- 0 funds opened new Nanobiotix positions in Q2 2022 and 0 closed out.
- The largest Nanobiotix seller in Q2 2022 was Woodline Partners, an estimated $23K sold.
Based on aggregated 13F filings for Q2 2022.